Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 59 of 1714:
49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type II, alpha 2 MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type I, beta MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
sodium channel, voltage-gated, type I, alpha MIANSERIN Sodium Channel, Site 2 80% 4.194uM 3.826uM View
dopamine receptor 2 TIAPRIDE Dopamine D2L 80% 1.232uM .411uM View
epidermal growth factor receptor MITOXANTRONE Protein Tyrosine Kinase, EGF Receptor 80% 5.3859uM NoneNone View
Protein-tyrosine kinase, Fyn ZIRCONIUM(IV) CHLORIDE Protein Tyrosine Kinase, Fyn 80% 2.921uM NoneNone View
lymphocyte protein tyrosine kinase (mapped) LEVODOPA Protein Tyrosine Kinase, Lck 80% 3.729uM NoneNone View
sodium channel, voltage-gated, type III, alpha PIPAMAZINE Sodium Channel, Site 2 80% 2.686uM 2.451uM View
sodium channel, voltage-gated, type II, beta PIPAMAZINE Sodium Channel, Site 2 80% 2.686uM 2.451uM View
sodium channel, voltage-gated, type II, alpha 2 PIPAMAZINE Sodium Channel, Site 2 80% 2.686uM 2.451uM View
sodium channel, voltage-gated, type I, beta PIPAMAZINE Sodium Channel, Site 2 80% 2.686uM 2.451uM View
sodium channel, voltage-gated, type I, alpha PIPAMAZINE Sodium Channel, Site 2 80% 2.686uM 2.451uM View
sodium channel, voltage-gated, type IV, beta PIPAMAZINE Sodium Channel, Site 2 80% 2.686uM 2.451uM View
sodium channel associated protein 1 PIPAMAZINE Sodium Channel, Site 2 80% 2.686uM 2.451uM View
calcium channel, voltage-dependent, gamma subunit 1 DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, beta 4 subunit DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
Cytochrom P450-2D6 monooxygenase CARMOFUR CYP450-2D6 Inhibition 79% 5uM NoneNone View
Cytochrom P450-2D6 monooxygenase RISPERIDONE CYP450-2D6 Inhibition 79% 5.2734uM NoneNone View
Cytochrom P450-2D6 monooxygenase GENTIAN VIOLET CYP450-2D6 Inhibition 79% .8244uM NoneNone View
Cytochrom P450-2C19 monooxygenase PODOPHYLLOTOXIN CYP450-2C19 Inhibition 79% 5uM NoneNone View
ATPase, Na+/K+ transporting, alpha 4 polypeptide GRAMICIDIN ATPase, Na+/K+ 79% 5.143uM NoneNone View
ATPase, Na+/K+ transporting, alpha 3 polypeptide GRAMICIDIN ATPase, Na+/K+ 79% 5.143uM NoneNone View
ATPase, Na+/K+ transporting, alpha 2 polypeptide GRAMICIDIN ATPase, Na+/K+ 79% 5.143uM NoneNone View
ATPase, Na+/K+ transporting, alpha 1 polypeptide GRAMICIDIN ATPase, Na+/K+ 79% 5.143uM NoneNone View
ATPase, Na+/K+ transporting, beta 1 polypeptide GRAMICIDIN ATPase, Na+/K+ 79% 5.143uM NoneNone View
ATPase, Na+/K+ transporting, beta 3 polypeptide GRAMICIDIN ATPase, Na+/K+ 79% 5.143uM NoneNone View
ATPase, Na+/K+ transporting, beta 2 polypeptide GRAMICIDIN ATPase, Na+/K+ 79% 5.143uM NoneNone View
ATPase, (Na+)/K+ transporting, beta 4 polypeptide GRAMICIDIN ATPase, Na+/K+ 79% 5.143uM NoneNone View
tachykinin receptor 2 GRAMICIDIN Tachykinin NK2 79% 4.564uM 1.521uM View
cholinergic receptor, muscarinic 1 IVERMECTIN Muscarinic M1 79% 4.9441uM 1.1907uM View
ATPase, Na+/K+ transporting, beta 3 polypeptide HEXACHLOROPHENE ATPase, Na+/K+ 78% 6.1319uM NoneNone View
ATPase, Na+/K+ transporting, beta 2 polypeptide HEXACHLOROPHENE ATPase, Na+/K+ 78% 6.1319uM NoneNone View
ATPase, (Na+)/K+ transporting, beta 4 polypeptide HEXACHLOROPHENE ATPase, Na+/K+ 78% 6.1319uM NoneNone View
ATPase, Na+/K+ transporting, alpha 4 polypeptide HEXACHLOROPHENE ATPase, Na+/K+ 78% 6.1319uM NoneNone View
cholinergic receptor, muscarinic 4 SERTRALINE Muscarinic M4 78% 2.6309uM .3669uM View
5-hydroxytryptamine (serotonin) receptor 1A OXICONAZOLE Serotonin 5-HT1A 78% 5.5774uM 3.1871uM View
5-hydroxytryptamine (serotonin) receptor 1B EBASTINE Serotonin 5-HT1B 78% 2.314uM 1.4171uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 CINNARIZINE Adrenergic, Norepinephrine Transporter 78% 2.832uM 2.808uM View
adrenergic receptor, alpha 2b PROMETHAZINE Adrenergic alpha2C 78% 2.431uM .353uM View
adrenergic receptor, alpha 2c (Non-specific probe) PROMETHAZINE Adrenergic alpha2C 78% 2.431uM .353uM View
adrenergic receptor, beta 3 4-NONYLPHENOL Adrenergic beta3 78% 4.19uM 3.142uM View
melanocortin 5 receptor CETYLPYRIDINIUM BROMIDE Melanocortin MC5 78% 3.726uM 3.495uM View
Cytochrom P450-2D6 monooxygenase STANOZOLOL CYP450-2D6 Inhibition 78% 9.274uM NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) RALOXIFENE CYP450-2C9 Inhibition 78% 2uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 RALOXIFENE CYP450-2C9 Inhibition 78% 2uM NoneNone View
opioid receptor, delta 1 RALOXIFENE Opiate delta 78% 6.644uM 2.342uM View
5-hydroxytryptamine (serotonin) receptor 2C RALOXIFENE Serotonin 5-HT2C 78% 1.178uM .617uM View
androgen receptor LACIDIPINE Testosterone 78% 3.918uM 2.612uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 MODAFINIL Dopamine Transporter 78% 1.832uM 1.456uM View
aldo-keto reductase family 1, member B4 (aldose reductase) SULFASALAZINE Aldose Reductase 78% 17.042uM NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) SULFASALAZINE Aldose Reductase 78% 17.042uM NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) SULFASALAZINE Aldose Reductase 78% 17.042uM NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) SULFASALAZINE Aldose Reductase 78% 17.042uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C HALOPROGIN Serotonin 5-HT2C 78% 2.602uM 1.363uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 HALOPROGIN Adrenergic, Norepinephrine Transporter 78% 2.77uM 2.747uM View
5-hydroxytryptamine (serotonin) receptor 2A S-(-)-PROPRANOLOL Serotonin 5-HT2A 78% 1.883uM .538uM View
5-hydroxytryptamine (serotonin) receptor 1B DISULFIRAM Serotonin 5-HT1B 78% 4.72uM 2.145uM View
sodium channel, voltage-gated, type IX, alpha BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
sodium channel, voltage-gated, type VII, alpha BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
amiloride-sensitive cation channel 5, intestinal BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
sodium channel, voltage-gated, type III, beta BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
sodium channel, voltage-gated, type XI, alpha BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
sodium channel, voltage-gated, type I, beta BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
sodium channel, voltage-gated, type 10, alpha polypeptide BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
sodium channel, voltage-gated, type IV, alpha polypeptide BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
sodium channel, voltage-gated, type V, alpha polypeptide BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
sodium channel, voltage-gated, type II, beta BROMOCRIPTINE Sodium Channel, Site 2 78% 6.692uM 6.105uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, beta 1 subunit BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 BENZTROPINE Calcium Channel Type L, Benzothiazepine 82% 3.25uM 2.889uM View
cholinergic receptor, muscarinic 3 IVERMECTIN Muscarinic M3 82% 6.0626uM 1.285uM View
Sigma-2 Receptor BUTENAFINE Sigma2 82% .2547uM .1567uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 BUTENAFINE Serotonin Transporter 82% 1.4118uM .75uM View
histamine receptor H 2 PROMAZINE Histamine H2 82% 2.858uM 2.81uM View
adrenergic receptor, alpha 2a PYRILAMINE Adrenergic alpha2A 82% 2.976uM 1.116uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 PYRILAMINE Dopamine Transporter 82% .879uM .699uM View
cholinergic receptor, muscarinic 5 TERCONAZOLE Muscarinic M5 82% 4.362uM 3.134uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 TACRINE Adrenergic, Norepinephrine Transporter 82% .517uM .513uM View
calcium channel, voltage-dependent, beta 4 subunit PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, beta 3 subunit PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, beta 2 subunit PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, alpha 1F subunit PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, beta 1 subunit PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
adrenergic receptor, alpha 2a METERGOLINE Imidazoline I2, Central 82% 1.923uM 1.282uM View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) ASTEMIZOLE Protein Tyrosine Kinase, HER2 Receptor 81% 13.084uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, gamma subunit 7 DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, gamma subunit 6 DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, gamma subunit 5 DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, gamma subunit 4 DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, gamma subunit 3 DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, gamma subunit 2 DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, gamma subunit 1 DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, beta 4 subunit DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, beta 3 subunit DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, beta 2 subunit DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, alpha 1F subunit DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
calcium channel, voltage-dependent, beta 1 subunit DROPERIDOL Calcium Channel Type L, Phenylalkylamine 81% 4.165uM 4.049uM View
adrenergic receptor, alpha 2c (Non-specific probe) AMLODIPINE Adrenergic alpha2C 90% 1.8uM .261uM View
adrenergic receptor, alpha 2b AMLODIPINE Adrenergic alpha2C 90% 1.8uM .261uM View
sodium channel, nonvoltage-gated 1 gamma AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, nonvoltage-gated 1 beta AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, voltage-gated, type XI, alpha AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, nonvoltage-gated 1, gamma AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, nonvoltage-gated 1, delta AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, nonvoltage-gated 1 alpha AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, voltage-gated, type X, alpha AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, voltage-gated, type IX, alpha AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, voltage gated, type VIII, alpha AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
sodium channel, voltage-gated, type VII, alpha AMITRIPTYLINE Sodium Channel, Site 2 90% 2.288uM 2.088uM View
potassium voltage-gated channel, subfamily H, member 8 PROCHLORPERAZINE Potassium Channel HERG 90% 1.8481uM 1.5141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 PROCHLORPERAZINE Potassium Channel HERG 90% 1.8481uM 1.5141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 PROCHLORPERAZINE Potassium Channel HERG 90% 1.8481uM 1.5141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 PROCHLORPERAZINE Potassium Channel HERG 90% 1.8481uM 1.5141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 PROCHLORPERAZINE Potassium Channel HERG 90% 1.8481uM 1.5141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 PROCHLORPERAZINE Potassium Channel HERG 90% 1.8481uM 1.5141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 PROCHLORPERAZINE Potassium Channel HERG 90% 1.8481uM 1.5141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 PROCHLORPERAZINE Potassium Channel HERG 90% 1.8481uM 1.5141uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 PROCHLORPERAZINE Potassium Channel HERG 90% 1.8481uM 1.5141uM View
adenosine A1 receptor ALPHA-NAPHTHOFLAVONE Adenosine A1 90% 1.1325uM .6606uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 HEXACHLOROPHENE Serotonin Transporter 90% 4.3494uM 2.3106uM View
Protein-tyrosine kinase, Fyn SULOCTIDIL Protein Tyrosine Kinase, Fyn 90% .7221uM NoneNone View
dopamine receptor D3 SULOCTIDIL Dopamine D3 90% 2.1039uM .7145uM View
Sigma-2 Receptor FLUNARIZINE Sigma2 90% .062uM .038uM View
5-hydroxytryptamine receptor 6 TERFENADINE Serotonin 5-HT6 90% 1.306uM .606uM View
5-hydroxytryptamine (serotonin) receptor 2B METHAPYRILENE Serotonin 5-HT2B 90% .843uM .537uM View
5-hydroxytryptamine (serotonin) receptor 2B CINNARIZINE Serotonin 5-HT2B 90% .731uM .465uM View
5-hydroxytryptamine (serotonin) receptor 2C DIMENHYDRINATE Serotonin 5-HT2C 90% .634uM .332uM View
mitogen activated protein kinase 1 ZAFIRLUKAST Protein Serine/Threonine Kinase, ERK2 90% .538uM NoneNone View
mitogen-activated protein kinase 1 ZAFIRLUKAST Protein Serine/Threonine Kinase, ERK2 90% .538uM NoneNone View
cholinergic receptor, muscarinic 4 CYCLIZINE Muscarinic M4 90% .852uM .119uM View
cholinergic receptor, muscarinic 3 FLUNARIZINE Muscarinic M3 90% 1.479uM .313uM View
calcium channel, voltage-dependent, gamma subunit 8 FLUNARIZINE Calcium Channel Type L, Dihydropyridine 90% 1.012uM .65uM View
calcium channel, voltage-dependent, gamma subunit 7 FLUNARIZINE Calcium Channel Type L, Dihydropyridine 90% 1.012uM .65uM View
calcium channel, voltage-dependent, gamma subunit 6 FLUNARIZINE Calcium Channel Type L, Dihydropyridine 90% 1.012uM .65uM View
calcium channel, voltage-dependent, gamma subunit 5 FLUNARIZINE Calcium Channel Type L, Dihydropyridine 90% 1.012uM .65uM View
calcium channel, voltage-dependent, gamma subunit 4 FLUNARIZINE Calcium Channel Type L, Dihydropyridine 90% 1.012uM .65uM View
calcium channel, voltage-dependent, gamma subunit 3 FLUNARIZINE Calcium Channel Type L, Dihydropyridine 90% 1.012uM .65uM View
calcium channel, voltage-dependent, gamma subunit 2 FLUNARIZINE Calcium Channel Type L, Dihydropyridine 90% 1.012uM .65uM View
calcium channel, voltage-dependent, gamma subunit 1 FLUNARIZINE Calcium Channel Type L, Dihydropyridine 90% 1.012uM .65uM View
calcium channel, voltage-dependent, beta 4 subunit FLUNARIZINE Calcium Channel Type L, Dihydropyridine 90% 1.012uM .65uM View
calcium channel, voltage-dependent, beta 3 subunit FLUNARIZINE Calcium Channel Type L, Dihydropyridine 90% 1.012uM .65uM View
calcium channel, voltage-dependent, beta 2 subunit FLUNARIZINE Calcium Channel Type L, Dihydropyridine 90% 1.012uM .65uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit FLUNARIZINE Calcium Channel Type L, Dihydropyridine 90% 1.012uM .65uM View
calcium channel, voltage-dependent, alpha 1F subunit FLUNARIZINE Calcium Channel Type L, Dihydropyridine 90% 1.012uM .65uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit FLUNARIZINE Calcium Channel Type L, Dihydropyridine 90% 1.012uM .65uM View
calcium channel, voltage-dependent, gamma subunit 4 PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
calcium channel, voltage-dependent, gamma subunit 3 PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
calcium channel, voltage-dependent, gamma subunit 2 PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
calcium channel, voltage-dependent, gamma subunit 1 PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
calcium channel, voltage-dependent, beta 4 subunit PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
calcium channel, voltage-dependent, beta 3 subunit PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
calcium channel, voltage-dependent, beta 2 subunit PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
calcium channel, voltage-dependent, alpha 1F subunit PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
calcium channel, voltage-dependent, beta 1 subunit PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 PERHEXILINE Calcium Channel Type L, Benzothiazepine 89% 1.0569uM .9394uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) ZAFIRLUKAST CYP450-2C9 Inhibition 89% 2.2575uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 ZAFIRLUKAST CYP450-2C9 Inhibition 89% 2.2575uM NoneNone View
adrenergic receptor, alpha 2b SULOCTIDIL Adrenergic alpha2C 89% 3.446uM .5007uM View
adrenergic receptor, alpha 2c (Non-specific probe) SULOCTIDIL Adrenergic alpha2C 89% 3.446uM .5007uM View
Sigma-2 Receptor CINNARIZINE Sigma2 89% .161uM .099uM View
arachidonate 15-lipoxygenase, second type INDAPAMIDE Lipoxygenase 15-LO 89% 2.918uM NoneNone View
arachidonate 15-lipoxygenase INDAPAMIDE Lipoxygenase 15-LO 89% 2.918uM NoneNone View
arachidonate 15-lipoxygenase INDAPAMIDE Lipoxygenase 15-LO 89% 2.918uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 CINNARIZINE Dopamine Transporter 89% 1.641uM 1.304uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 MONTELUKAST Dopamine Transporter 89% 2.601uM 2.067uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 THIORIDAZINE Dopamine Transporter 89% 2.376uM 1.888uM View
prostaglandin-endoperoxide synthase 1 FELBINAC Cyclooxygenase COX-1 89% .894uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) FELBINAC Cyclooxygenase COX-1 89% .894uM NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 ERGOCORNINE CYP450-3A4 Inhibition 89% .5uM NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 ALPHA-ERGOCRYPTINE CYP450-3A4 Inhibition 89% .6uM NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 TACROLIMUS CYP450-3A4 Inhibition 89% 1uM NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) CANDESARTAN CYP450-2C9 Inhibition 89% 3uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 CANDESARTAN CYP450-2C9 Inhibition 89% 3uM NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) NOSCAPINE CYP450-2C9 Inhibition 89% 8.1773uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 NOSCAPINE CYP450-2C9 Inhibition 89% 8.1773uM NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) CLOSANTEL CYP450-2C9 Inhibition 89% 2uM NoneNone View